Atlas Trials

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

Clinical trial NCT04656795 · COMPLETED

Trial details

NCT number
NCT04656795
Sponsor
Tanabe Pharma America, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal ImpairmentNormal Renal Function
Start date
2020-12-02
Primary completion
2021-12-04
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.